FDA clears Orthovita's Vitoss bone filler:
This article was originally published in Clinica
Executive Summary
Orthovita has received US FDA 510(k) clearance for its synthetic cancellous bone void filler for repairing bone defects in the spine, extremities and pelvis. The Vitoss scaffold, is made of a resorbable calcium phosphate, which has a porous, fine-particle structure that allows the product to become saturated with marrow, blood and nutrients required for bone growth and remodelling. The product will be launched in February, making it the Malvern, Pennsylvania company's first product on the US orthopaedic market. It is already available for sale in Europe.